Behbahani Ali bought BDTX
December 12, 2025 · Form 4 insider transaction
Behbahani Ali bought 5,208 shares of Black Diamond Therapeutics, Inc. at $2.76 per share, a transaction worth $14.4K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
5,208
Price
$2.76
Total value
$14.4K
InsiderBehbahani Ali
RoleDirector, 10% owner
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateDecember 12, 2025
Filing dateDecember 15, 2025
Shares owned after86,649
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
These shares were issued in accordance with the Issuer's Fifth Amended and Restated Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for annual services as a non-employee director of the Issuer.; The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on December 11, 2025.